Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.25B |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$469M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$389M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$376M |
| 5 |
Welltower
WELL
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.94% |
| 2 | Healthcare | 10.15% |
| 3 | Financials | 8.13% |
| 4 | Industrials | 7.39% |
| 5 | Consumer Discretionary | 7.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCEL
4101
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $389K | ﹤0.01% |
23,486
+5,723
| +32% | +$104K |
|
4102
AMES National
ATLO
$280M
| $388K | ﹤0.01% |
18,967
+1,263
| +7% | +$31.9K |
|
4103
Peabody Energy
BTU
$2.98B
| $387K | ﹤0.01% |
133,635
+6,861
| +5% | +$43.9K |
|
4104
iShares Currency Hedged MSCI Japan ETF
HEWJ
$752M
| $385K | ﹤0.01% |
14,160
-5,114
| -27% | -$157K |
|
4105
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$740M
| $385K | ﹤0.01% |
4,941
+51
| +1% | +$3.88K |
|
4106
Northrim BanCorp
NRIM
$595M
| $385K | ﹤0.01% |
57,048
+9,040
| +19% | +$77.9K |
|
|
PTLA
4107
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $385K | ﹤0.01% |
15,000
-1,700
| -10% | -$21.2K |
|
4108
Orion
OEC
$377M
| $384K | ﹤0.01% |
51,471
+16,456
| +47% | +$238K |
|
4109
Spok Holdings
SPOK
$239M
| $384K | ﹤0.01% |
35,968
-15,469
| -30% | -$166K |
|
|
NPKI
4110
NPK International
NPKI
$1.18B
| $384K | ﹤0.01% |
428,096
+49,120
| +13% | +$184K |
|
|
ODT
4111
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $384K | ﹤0.01% |
13,910
-32
| -0.2% | -$933 |
|
4112
Alaunos Therapeutics
TCRT
$4.81M
| $383K | ﹤0.01% |
1,043
-10
| -0.9% | -$5.17K |
|
4113
Hecla Mining Co Series B Preferred Stock
HL.PRB
$10.2M
| $382K | ﹤0.01% |
8,310
+250
| +3% | +$13K |
|
4114
Prothena Corp
PRTA
$473M
| $382K | ﹤0.01% |
35,789
+7,191
| +25% | +$87.1K |
|
4115
Greenlight Captial
GLRE
$503M
| $381K | ﹤0.01% |
64,132
-45,676
| -42% | -$393K |
|
4116
Constellium
CSTM
$4.05B
| $378K | ﹤0.01% |
72,705
-344,267
| -83% | -$3.7M |
|
4117
NI Holdings
NODK
$315M
| $378K | ﹤0.01% |
27,847
+11,338
| +69% | +$166K |
|
|
SBR
4118
Sabine Royalty Trust
SBR
$1.06B
| $378K | ﹤0.01% |
13,678
-40
| -0.3% | -$1.42K |
|
|
OSG
4119
DELISTED
Overseas Shipholding Group Inc.
OSG
| $378K | ﹤0.01% |
166,811
+15,868
| +11% | +$32K |
|
|
BLDP
4120
Ballard Power Systems
BLDP
$784M
| $376K | ﹤0.01% |
49,392
+39,611
| +405% | +$385K |
|
4121
FS KKR Capital
FSK
$3.39B
| $376K | ﹤0.01% |
31,359
-3,916
| -11% | -$83.8K |
|
4122
Nuveen Core Equity Alpha Fund
JCE
$289M
| $376K | ﹤0.01% |
35,106
-63,582
| -64% | -$859K |
|
4123
Transcat
TRNS
$893M
| $376K | ﹤0.01% |
14,207
+2,342
| +20% | +$70.3K |
|
4124
ETRACS MarketVector Business Development Companies Liquid Index ETN due Apr 26 2041
BDCZ
$16.6M
| $375K | ﹤0.01% |
+33,572
| New | +$603K |
|
4125
Chemung Financial Corp
CHMG
$396M
| $375K | ﹤0.01% |
11,366
+2,034
| +22% | +$73.7K |
|
Similar funds
Wells Fargo's Q1 2020 Portfolio in Review
As of Q1 2020, Wells Fargo held 7,374 positions worth $289B, down 22% from $371B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wells Fargo withdrew a net $9.44B in Q1 2020, closing 426 positions and reducing 2,808 holdings. Its most notable exit was Medicines Co, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wells Fargo opened a new position in Reynolds Consumer Products worth $262M.
- Wells Fargo's largest Q1 2020 buy was Reynolds Consumer Products: 8,970,912 shares worth $262M.
- Wells Fargo added most to Vanguard Morningstar Mid-Cap ETF in Q1 2020, an estimated $1.04B increase.
- Wells Fargo's biggest Q1 2020 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.25B.
- Wells Fargo fully exited Medicines Co in Q1 2020, selling an estimated $111M.
- Wells Fargo's ten largest holdings make up 16% of its $289B portfolio in Q1 2020.
- Wells Fargo opened 626 new positions and closed 426 in Q1 2020.
- Wells Fargo's portfolio value fell 22% quarter-over-quarter to $289B.
Based on Wells Fargo's 13F filing for Q1 2020, filed 14 May 2020.